The conversation about AI in pharmacovigilance has typically focused on automating individual steps in the case processing workflow.
A greater opportunity lies in broader, more autonomous signal management, which could transform the speed of ICSR processing from days to minutes.
For all the attention on AI’s potential to streamline operational processes in pharmacovigilance, such as case processing, the more transformative opportunity is in making signal management more autonomous.
Check out the rest of the feature here
